REQUEST A DEMO
Total
USD $0.00
Search more companies

Med-Ekspress-Diagnostika OOO (Naro-Fominsk) (Russia)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Med-Ekspress-Diagnostika OOO Profile Updated: August 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Russian Download a sample report

Med-Ekspress-Diagnostika OOO (Naro-Fominsk) is an enterprise in Russia, with the main office in Naro-Fominsk. It operates in the Pharmaceutical and Medicine Manufacturing sector. The company was established on October 31, 2011. In its most recent financial highlights, the company reported a net sales revenue increase of 28.92% in 2023. Its total assets grew by 70.48% over the same period. The enterprise’s net profit margin increased by 17.13% in 2023.

Headquarters
Karla Marksa, 1, 52
Naro-Fominsk; Moscow Oblast; Postal Code: 143306

Contact Details: Purchase the Med-Ekspress-Diagnostika OOO (Naro-Fominsk) report to view the information.

Basic Information
Outstanding Shares:
Purchase the Med-Ekspress-Diagnostika OOO (Naro-Fominsk) report to view the information.
Registered Capital:
Purchase the Med-Ekspress-Diagnostika OOO (Naro-Fominsk) report to view the information.
Incorporation Date:
October 31, 2011
Key Executives
Purchase this report to view the information.
General Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Med-Ekspress-Diagnostika OOO (Naro-Fominsk) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
28.92%
Total operating revenue
28.92%
Operating profit (EBIT)
162.21%
Net Profit (Loss) for the Period
263.77%
Total assets
70.48%
Total equity
4498.26%
Operating Profit Margin (ROS)
15.36%
Net Profit Margin
17.13%
Return on Equity (ROE)
-1138.75%
Quick Ratio
0.5%
Cash Ratio
-0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?